Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
19 February, 2019 18:37 IST
GlobalSpace Tech acquires 70.80% stake in Miljon Medi APP LLP
Source: IRIS | 14 Jun, 2018, 11.07AM
Comments  |  Post Comment

GlobalSpace Technologies, a fast growing new-age technology company today announced acquisition of 70.80% stake in Miljon Medi APPLLP for an undisclosed sum.

Miljon Medi APP LLP is a health tech startup with B2B Digital Platform (Platform) that connects Generics pharmaceutical manufacturers to the entire Pharma channel till retail chemist. Company claims to have some of the leading Generics Manufacturers already on the Platform with an existing network of around 73 distributors & 9380 Chemists as its active users. Company’s vision is to enable quality & certified generics reach the last mile so as to benefit the patients.

For GlobalSpace, it's a strategic acquisition which would further consolidate its vision of creating truly integrated digital healthcare ecosystem. Company is having thought leadership in creating digital platform for Pharma sales force & Doctors.

Krishna Singh, MD, GlobalSpace said, ''This is a synergistic acquisition for us, we have already built an evolved digital platform for Pharma distribution including ERP, Mobile & Web app, it would provide the much-needed technical scalability & viability to Miljon Medi App. Merging GlobalSpace's tech platform with Miljon's existing network would surely provide us the initial impetus to grow this platform to be India's largest Pharma channel network.''



Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Sector
Cipla, Wellthy Therapeutics announce partnership to offer digital therapeutics - 19-Feb-2019 10:58
Glenmark Pharma receives ANDA approval for Clobetasol propionate foam - 18-Feb-2019 10:45
L&T Construction secures contract for design and construction of major airport - 18-Feb-2019 10:42
Lupin launches Clobazam oral suspension - 15-Feb-2019 16:37
Zydus gets USFDA nod for Triamterene & Hydrochlorothiazide capsules - 13-Feb-2019 13:10
L&T Construction bags contract for construction of hospitals - 13-Feb-2019 11:56
Strides receives USFDA approval for Triamcinolone Acetonide cream - 13-Feb-2019 11:52
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer